Drug Trial Radar · NCT04530123
Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet
Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
102
Actual
Start
Jun 23, 2022
Primary completion
Dec 9, 2025
Study completion Jan 8, 2026
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Aug 28, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim of the study is to assess if TAK-101 can reduce gluten related symptoms and immune activation in adult participants with celiac disease (CeD) on a gluten-free diet (GFD). Participants will receive TAK-101 and/or placebo through the vein on Day 1 and Day 8. All participants will receive active treatment at Week 24.
Conditions
- Celiac Disease
Interventions
PlaceboDrug
TAK-101 matching placebo intravenous infusion
TAK-101Drug
TAK 101 intravenous infusion
GlutenDietary supplement
Powder form (vital wheat gluten)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Interferon-gamma Spot Forming Units (IFN-γ SFUs) in Human Leukocyte Antigens Density Quotient (HLA-DQ2.5-positive) Participants Based on Results of a Gliadin-Specific Enzyme-Linked Immunospot (ELISpot) AssayTime frame: Baseline (Day 15), Week 3 (Day 20)
Locations
48 sites in 4 countries. Site status is shown where the registry gives one.
One of a Kind Clinical Research Center LLC
Scottsdale, Arizona
Gastroenterology and Liver Institute
Escondido, California
Cadena Care Institute, Inc.
Poway, California
Asthma and Allergy Associates, PC
Colorado Springs, Colorado
GCP Clinical Research, LLC
Tampa, Florida
Agile Clinical Research Trials
Atlanta, Georgia
Lemah Creek Clinical Research
Burr Ridge, Illinois
Gastroenterology Associates, PA
Rockford, Illinois
Rockford Gastroenterology Associates, Ltd.
Rockford, Illinois
Berkshire Medical Center
New Albany, Indiana
Gastroenterology Health Partners, PLLC
New Albany, Indiana
Boston Specialists
Boston, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Berkshire Medical Center, Inc.
Pittsfield, Massachusetts
Clinical Research Institute of Michigan, LLC
Chesterfield, Michigan
Wellness Clinical Research
Chesterfield, Michigan
Mayo Clinic - Rochester
Rochester, Minnesota
Albuquerque Clinical Trials, Inc.
Albuquerque, New Mexico
Basil Clinical
Inwood, New York
Mount Sinai
New York, New York
Columbia University Medical Center. New York Presbyterian Hospital
New York, New York
East Carolina Gastroenterology, PA
Jacksonville, North Carolina
GI Alliance-Rhode Island
Providence, Rhode Island
Amel Med LLC
Georgetown, Texas
Care Access Research - Salt Lake City
Ogden, Utah
St Vincent's Hospital Melbourne
Fitzroy, Australia
Mater Hospital Brisbane
South Brisbane, Australia
Royal Melbourne Hospital
Parkville, AU, Australia
Emeritus Research, Sydney
Botany, NS, Australia
Coral Sea Clinical Research Institute
North Mackay, Queensland, Australia
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
Emeritus Research, Melbourne
Camberwell, Victoria, Australia
The Northern Hospital
Epping, Victoria, Australia
St John of God Midland
Midland, Western Australia, Australia
Gastroenterology and Internal Medicine Research Institute (GIRI)
Edmonton, Alberta, Canada
PerCuro Clinical Research Ltd.
Victoria, British Columbia, Canada
McMaster University
Hamilton, Ontario, Canada
Scott Shulman Medicine Professional Corporation
North Bay, Ontario, Canada
DIEX Recherche Quebec Inc.
Québec, Quebec, Canada
Showing 40 of 48 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.